{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:24:55Z","timestamp":1791987895343,"version":"4.4.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Swedish government","award":["ALFGBG-983782"],"award-info":[{"award-number":["ALFGBG-983782"]}]},{"name":"Swedish government","award":["ALFGBG-966066"],"award-info":[{"award-number":["ALFGBG-966066"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Despite important advances in the management of primary adrenal insufficiency (PAI), prognosis in these patients remains poor. Data on mortality in PAI has not been entirely consistent, and to date, no systematic synthesis has been performed. The aim of this study was to conduct a systematic review and a meta-analysis to synthesize available evidence on mortality in adult patients with PAI including congenital adrenal hyperplasia (CAH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>This is a systematic review and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Medline, Cochrane CENTRAL, Web of Science, and Embase databases were searched for studies on mortality in PAI. The results were screened by 2 reviewers by titles and abstracts, and selected articles were subsequently reviewed in full text. Observational studies on mortality compared to a reference population were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of the 6238 reports identified, 9 reports were included in the systematic review, with a total population of 13 969 patients. Two of the 9 studies included overlapping population; therefore, only 7 studies were included in the meta-analysis (9876 patients). Four studies assessed mortality utilizing hazard ratio (HR) with a pooled HR of 2.51 (95% confidence interval [CI] 1.47-4.31, I2 = 86.1%); 3 studies used standardized mortality ratio (SMR) with a pooled SMR of 2.49 (95% CI 0.99-6.28, I2 = 97.9%). The main cause of death was cardiovascular disease. A sub-analysis of patients with CAH showed a pooled HR of 2.88 (95% CI 1.38-6.01, I2 = 90.3%), with the main cause of death being adrenal crisis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Mortality in patients with PAI was increased 2.5-fold compared to the reference population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf186","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T12:07:24Z","timestamp":1757678844000},"page":"S53-S60","source":"Crossref","is-referenced-by-count":13,"title":["Increased mortality in primary adrenal insufficiency: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0138-0178","authenticated-orcid":false,"given":"Konstantinos","family":"Dalakas","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Endocrinology, Sahlgrenska University Hospital , Bl\u00e5 Str\u00e5ket 5, Gothenburg 413 45 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2639-1520","authenticated-orcid":false,"given":"Francesca","family":"Allosso","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d , Naples 80138 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4680-3058","authenticated-orcid":false,"given":"Christian","family":"Basile","sequence":"additional","affiliation":[{"name":"Department of Clinical Science and Education, S\u00f6dersjukhuset, Karolinska Institutet , Stockholm 17177 ,","place":["Sweden"]},{"name":"ANMCO Research Center, Heart Care Foundation , Florence 50121 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9535-8632","authenticated-orcid":false,"given":"Ragnhildur","family":"Bergthorsdottir","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Endocrinology, Sahlgrenska University Hospital , Bl\u00e5 Str\u00e5ket 5, Gothenburg 413 45 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1660-1973","authenticated-orcid":false,"given":"Dimitrios","family":"Chantzichristos","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Endocrinology, Sahlgrenska University Hospital , Bl\u00e5 Str\u00e5ket 5, Gothenburg 413 45 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0040-7930","authenticated-orcid":false,"given":"Eva","family":"Hessman","sequence":"additional","affiliation":[{"name":"Biomedical Library, Gothenburg University Library, University of Gothenburg , Gothenburg 40530 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2876-6089","authenticated-orcid":false,"given":"Bright I","family":"Nwaru","sequence":"additional","affiliation":[{"name":"Krefting Research Centre, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg 40530 ,","place":["Sweden"]},{"name":"Wallenberg Centre for Molecular and Translational Medicine, Institute of Medicine, University of Gothenburg , Gothenburg 40530 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8287-2448","authenticated-orcid":false,"given":"Emanuele","family":"Bobbio","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital , Gothenburg 413 45 ,","place":["Sweden"]},{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg , Gothenburg 40530 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5674-635X","authenticated-orcid":false,"given":"Daniela","family":"Pasquali","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d , Naples 80138 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3484-8440","authenticated-orcid":false,"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Endocrinology, Sahlgrenska University Hospital , Bl\u00e5 Str\u00e5ket 5, Gothenburg 413 45 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8993-2071","authenticated-orcid":false,"given":"Daniela","family":"Esposito","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Endocrinology, Sahlgrenska University Hospital , Bl\u00e5 Str\u00e5ket 5, Gothenburg 413 45 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"issue":"9935","key":"2025093010515811600_lvaf186-B1","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/S0140-6736(13)61684-0","article-title":"Adrenal insufficiency","volume":"383","author":"Charmandari","year":"2014","journal-title":"Lancet"},{"issue":"10274","key":"2025093010515811600_lvaf186-B2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0140-6736(21)00136-7","article-title":"Adrenal insufficiency","volume":"397","author":"Husebye","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"2025093010515811600_lvaf186-B3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S2213-8587(14)70142-1","article-title":"Diagnosis and management of adrenal insufficiency","volume":"3","author":"Bancos","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2025093010515811600_lvaf186-B4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/cen.12603","article-title":"Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy","volume":"82","author":"Johannsson","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2025093010515811600_lvaf186-B5","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison's disease: a population-based study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025093010515811600_lvaf186-B6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1365-2265.2008.03340.x","article-title":"Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency","volume":"69","author":"Bensing","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2025093010515811600_lvaf186-B7","doi-asserted-by":"publisher","first-page":"e2759","DOI":"10.1210\/clinem\/dgab096","article-title":"Increased mortality risk in patients with primary and secondary adrenal insufficiency","volume":"106","author":"Ngaosuwan","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025093010515811600_lvaf186-B8","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1210\/clinem\/dgab063","article-title":"Cardiovascular disease in patients with primary and secondary adrenal insufficiency and the role of comorbidities","volume":"106","author":"Ngaosuwan","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"10354","key":"2025093010515811600_lvaf186-B9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK","volume":"400","author":"Conrad","year":"2022","journal-title":"Lancet"},{"key":"2025093010515811600_lvaf186-B10","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"jan02 1","key":"2025093010515811600_lvaf186-B11","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"2025093010515811600_lvaf186-B12","doi-asserted-by":"publisher","first-page":"e076582","DOI":"10.1136\/bmjopen-2023-076582","article-title":"Mortality in patients with adrenal insufficiency: a protocol for a systematic review and meta-analysis","volume":"14","author":"Allosso","year":"2024","journal-title":"BMJ Open"},{"key":"2025093010515811600_lvaf186-B13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2025093010515811600_lvaf186-B14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"issue":"1","key":"2025093010515811600_lvaf186-B15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan \u2013 a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"11","key":"2025093010515811600_lvaf186-B16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"7124","key":"2025093010515811600_lvaf186-B17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/bmj.316.7124.61","article-title":"Bias in location and selection of studies","volume":"316","author":"Egger","year":"1998","journal-title":"BMJ"},{"issue":"9","key":"2025093010515811600_lvaf186-B18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"2025093010515811600_lvaf186-B19","doi-asserted-by":"publisher","first-page":"e2207","DOI":"10.1210\/clinem\/dgaa140","article-title":"Patients with APECED have increased early mortality due to endocrine causes, malignancies and infections","volume":"105","author":"Borchers","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025093010515811600_lvaf186-B20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1530\/EJE-08-0550","article-title":"Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death","volume":"160","author":"Erichsen","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2025093010515811600_lvaf186-B21","doi-asserted-by":"publisher","first-page":"E2715","DOI":"10.1210\/jc.2014-2957","article-title":"Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"99","author":"Falhammar","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025093010515811600_lvaf186-B22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1530\/EJE-17-0895","article-title":"Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia","volume":"178","author":"Jenkins-Jones","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2025093010515811600_lvaf186-B23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3803\/EnM.2021.1328","article-title":"Epidemiology and long-term adverse outcomes in Korean patients with congenital adrenal hyperplasia: a nationwide study","volume":"37","author":"Kim","year":"2022","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"7571","key":"2025093010515811600_lvaf186-B24","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/s0140-6736(68)90948-3","article-title":"Epidemiological and clinical picture of Addison's disease","volume":"2","author":"Mason","year":"1968","journal-title":"Lancet"},{"issue":"1","key":"2025093010515811600_lvaf186-B25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/cen.13609","article-title":"Mortality data from the European Adrenal Insufficiency Registry-patient characterization and associations","volume":"89","author":"Quinkler","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2025093010515811600_lvaf186-B26","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/joim.13731","article-title":"Increased risk of hospitalization, intensive care and death due to COVID-19 in patients with adrenal insufficiency: a Swedish nationwide study","volume":"295","author":"Bergthorsdottir","year":"2024","journal-title":"J Intern Med"},{"key":"2025093010515811600_lvaf186-B27","doi-asserted-by":"publisher","first-page":"3691913","DOI":"10.1155\/2017\/3691913","article-title":"Increased cardiovascular risk in patients with adrenal insufficiency: a short review","volume":"2017","author":"Rahvar","year":"2017","journal-title":"Biomed Res Int"},{"issue":"8","key":"2025093010515811600_lvaf186-B28","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1210\/clinem\/dgab347","article-title":"Mortality risk in patients with adrenal insufficiency using prednisolone or hydrocortisone: a retrospective cohort study","volume":"106","author":"Ngaosuwan","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025093010515811600_lvaf186-B29","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","author":"Arlt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025093010515811600_lvaf186-B30","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1530\/EJE-13-0128","article-title":"Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE)","volume":"168","author":"Han","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025093010515811600_lvaf186-B31","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1210\/jc.2011-1926","article-title":"Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation","volume":"97","author":"Johannsson","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025093010515811600_lvaf186-B32","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1185\/03007995.2014.925865","article-title":"Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments","volume":"30","author":"Johannsson","year":"2014","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"2025093010515811600_lvaf186-B33","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1210\/jc.2013-4253","article-title":"Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of Addison's disease: a randomized clinical trial","volume":"99","author":"Oksnes","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025093010515811600_lvaf186-B34","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1210\/jc.2017-01928","article-title":"Primary adrenal insufficiency: managing mineralocorticoid replacement therapy","volume":"103","author":"Esposito","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025093010515811600_lvaf186-B35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/jc.2016-2522","article-title":"Clinical and immunological characteristics of autoimmune Addison disease: a nationwide Swedish multicenter study","volume":"102","author":"Dalin","year":"2017","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf186\/64259722\/lvaf186.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/4\/S53\/64259722\/lvaf186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/4\/S53\/64259722\/lvaf186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T14:56:02Z","timestamp":1759244162000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/193\/4\/S53\/8253265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf186","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,9,12]]}}}